Invention Grant
US08206718B2 Expression and export of angiogenesis inhibitors as immunofusins
有权
血管生成抑制剂作为免疫蛋白的表达和输出
- Patent Title: Expression and export of angiogenesis inhibitors as immunofusins
- Patent Title (中): 血管生成抑制剂作为免疫蛋白的表达和输出
-
Application No.: US11475627Application Date: 2006-06-27
-
Publication No.: US08206718B2Publication Date: 2012-06-26
- Inventor: Kin-Ming Lo , Yue Li , Stephen D. Gillies
- Applicant: Kin-Ming Lo , Yue Li , Stephen D. Gillies
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Olson & Cepuritis, Ltd.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K14/00

Abstract:
A homodimeric protein of the invention has angiogenesis inhibiting activity. The homodimeric protein consists of two identical fusion proteins bound together as a homodimer. Each fusion protein comprises an immunoglobulin Fc region and a first target protein linked to the immunoglobulin Fc region. The first target protein has an angiogenesis inhibiting activity of angiostatin or endostatin, and is selected from the group consisting of a plasminogen fragment and a collagen XVIII fragment. The immunoglobulin Fc region comprises a hinge region, a CH2 region, and a CH3 region.
Public/Granted literature
- US20070009538A1 Expression and export of angiogenesis inhibitors as immunofusins Public/Granted day:2007-01-11
Information query